Compare
Sanara MedTech Inc. vs Alpha PRO Tech Ltd vs Establishment Labs Holdings Inc. vs Myomo, Inc.
| Latest fiscal year | Sanara MedTech Inc. SMTI | Alpha PRO Tech Ltd APT | Establishment Labs Holdings Inc. ESTA | Myomo, Inc. MYO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $103.12M | $59.14M | $211.08M | $40.93M |
| Revenue growth (YoY) | +19.0% | +2.3% | +27.1% | +25.7% |
| Gross margin | 92.7% | 38.1% | 69.3% | 65.7% |
| Operating margin | 7.1% | 6.5% | -18.5% | -35.2% |
| Net margin | -36.4% | 6.0% | -24.2% | -38.1% |
| Net income | -$37.56M | $3.53M | -$51.06M | -$15.57M |
| EPS (Diluted) | -$4.36 | $0.33 | -$1.72 | -$0.37 |
| Operating cash flow | $6.79M | $2.37M | -$50.89M | -$14.51M |
| Free cash flow | $2.16M | $1.73M | -$56.94M | -$16.25M |
| Cash & equivalents | $16.58M | $16.99M | $75.57M | $14.13M |
| Total assets | $72.94M | $74.13M | $357.17M | $38.64M |
| Total liabilities | $67.01M | $11.65M | $333.62M | $27.23M |
| Shareholders' equity | $5.94M | $62.48M | $23.55M | $11.40M |
| Return on year-end equity | -632.5% | 5.7% | -216.9% | -136.6% |
| Shares outstanding | 8.95M | 10.13M | 29.30M | 38.47M |
Revenue, most recent five fiscal years
| Fiscal year | Sanara MedTech Inc. | Alpha PRO Tech Ltd | Establishment Labs Holdings Inc. | Myomo, Inc. |
|---|---|---|---|---|
| Latest | $103.12M Ended 2025-12-31 | $59.14M Ended 2025-12-31 | $211.08M Ended 2025-12-31 | $40.93M Ended 2025-12-31 |
| 1 year earlier | $86.67M Ended 2024-12-31 | $57.84M Ended 2024-12-31 | $166.03M Ended 2024-12-31 | $32.55M Ended 2024-12-31 |
| 2 years earlier | $64.99M Ended 2023-12-31 | $61.23M Ended 2023-12-31 | $165.15M Ended 2023-12-31 | $19.24M Ended 2023-12-31 |
| 3 years earlier | $45.84M Ended 2022-12-31 | $61.98M Ended 2022-12-31 | $161.70M Ended 2022-12-31 | $15.56M Ended 2022-12-31 |
| 4 years earlier | $24.14M Ended 2021-12-31 | $68.64M Ended 2021-12-31 | $126.68M Ended 2021-12-31 | $13.86M Ended 2021-12-31 |